A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
US: FDA approval not reviewed here
The registry reports not yet recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 3 · Not yet enrolling
Planned enrollment: 330 participants
Study ages: 18 Years and older
No results-posting date in this record
Read trial record and resultsChecked Nov 17, 2026